US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,858 | -2,291 | -1,726 | -1,156 | -3,287 |
| Depreciation Amortization | 685 | 493 | 324 | 149 | 977 |
| Accounts receivable | -4 | -2 | -7 | -3 | -40 |
| Accounts payable and accrued liabilities | 274 | 227 | 168 | 155 | 73 |
| Other Working Capital | 285 | 232 | 169 | 161 | 28 |
| Other Operating Activity | 1,312 | 1,080 | 875 | 631 | 1,191 |
| Operating Cash Flow | $-305 | $-262 | $-197 | $-64 | $-1,058 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 213 | 194 | 158 | 24 | 856 |
| Debt Repayment | N/A | -10 | N/A | N/A | N/A |
| Common Stock Issued | 85 | 85 | 35 | 25 | 275 |
| Other Financing Activity | -28 | -16 | -25 | -10 | -52 |
| Financing Cash Flow | $271 | $253 | $168 | $39 | $1,079 |
| Beginning Cash Position | 39 | 39 | 39 | 39 | 19 |
| End Cash Position | 5 | 30 | 10 | 15 | 39 |
| Net Cash Flow | $-34 | $-9 | $-29 | $-25 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -305 | -262 | -197 | -64 | -1,058 |
| Free Cash Flow | -305 | -262 | -197 | -64 | -1,058 |